To further investigate the cytotoxic effect of OTS514 in AML, CD34+ cells obtained from a patient with AML (AML-CD34+) and those from a healthy donor (normal-CD34+) were treated with OTS514, and assessed for colony forming ability. The gene discussed is CD34; the disease is acute myeloid leukemia.